Last reviewed · How we verify
NCT06714578
Construction of a Risk Screening Tool for New Psychoactive Substance Misuse Among Adolescents and Young Adults
trial testing Questionnaire and Physical Exam in Drug Misuse in 1,035 participants. Not yet recruiting.
15 August 2025
Quick facts
| Lead sponsor | Wei XIA, PhD |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 1,035 |
| Start date | 15 December 2024 |
| Primary completion | 15 August 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Questionnaire and Physical Exam — full drug profile →
Conditions studied
- Drug Misuse — all drugs for Drug Misuse →
- Addiction — all drugs for Addiction →
Sponsor
Wei XIA, PhD
Who can join
Adults 14 to 35, any sex, with Drug Misuse or Addiction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to construct a risk tool available for screening young adults and adolescents at high risk of drug misuse and provides a chance for early intervention to young adults and adolescents at high risk of drug misuse, which prevent the onset and development of drug addiction in the future.The main question it aims to answer is: 1. Explore the occurrence and influencing factors of new psychoactive substance misuse among young adults and adolescents; 2. Construct a risk prediction model for new psychoactive substance misuse among young adults and adolescents and conduct internal verification of the model; 3. Based on the results of the prediction model, select the optimal model to initially form a concise scale "Screening Tool for the Risk of New Psychoactive Substance Misuse among Young Adults and Adolescents"; 4. Conduct external verification of the tool, and revise and improve the screening tool, form the final version of the screening tool, and verify the application performance of the screening tool.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06714578
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Questionnaire and Physical Exam
Trials testing the same drug.
- NCT07469345 — Bruxism, Pelvic Pain, Erectile Dysfunction, and Anxiety in Young Adult Men · enrolling by invitation
- NCT06837584 — Control and Treatment of Outpatient Children With Asthma · not yet recruiting
- NCT07521813 — Psychiatric Disorders in Dermatiological Diseases · not yet recruiting
- NCT07276360 — Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · Phase 2 · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
Other Wei XIA, PhD trials
Trials by the same sponsor.
- NCT07020871 — Correlation of Dry Eye Disease, Problematic Smartphone Use and Sleep Quality in Adolescents and Young Adults · not yet recruiting
- NCT07019948 — The Correlation Between Sleep Quality and Sleep Aid Use and Dietary Patterns · not yet recruiting
- NCT07055334 — Development and Improvement of Home Rehabilitation Scheme for Preschool Children With Congenital Heart Disease After Ope · not yet recruiting
- NCT06461611 — Effect of Health Diary on Self-management in Adolescent Patients With Fixed Orthodontic Appliance · NA · recruiting
- NCT06396780 — Treatment Adherence And Influencing Factors in Children With Helicobacter Pylori Infection During Eradication Therapy · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06714578 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wei XIA, PhD
- Last refreshed: 18 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06714578.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing